151 related articles for article (PubMed ID: 9484914)
21. Multimodality treatment including postoperative radiation and concurrent chemotherapy with weekly docetaxel is feasible and effective in patients with oral and oropharyngeal cancer.
Kovács AF; Mose S; Böttcher HD; Bitter K
Strahlenther Onkol; 2005 Jan; 181(1):26-34. PubMed ID: 15660190
[TBL] [Abstract][Full Text] [Related]
22. Long-term follow-up after transoral laser microsurgery and adjuvant radiotherapy for advanced recurrent squamous cell carcinoma of the head and neck.
Christiansen H; Hermann RM; Martin A; Florez R; Kahler E; Nitsche M; Hille A; Steiner W; Hess CF; Pradier O
Int J Radiat Oncol Biol Phys; 2006 Jul; 65(4):1067-74. PubMed ID: 16750331
[TBL] [Abstract][Full Text] [Related]
23. Adjuvant chemo- and radiotherapy for poor prognosis head and neck squamous cell carcinomas.
Bernier J; Pfister DG; Cooper JS
Crit Rev Oncol Hematol; 2005 Dec; 56(3):353-64. PubMed ID: 15979887
[TBL] [Abstract][Full Text] [Related]
24. The chemotherapy of head and neck cancer.
de Mulder PH
Anticancer Drugs; 1999 Nov; 10 Suppl 1():S33-7. PubMed ID: 10630367
[TBL] [Abstract][Full Text] [Related]
25. [Treatment for recurrent head and neck carcinomas].
Tsukuda M
Gan To Kagaku Ryoho; 1998 Feb; 25(3):303-8. PubMed ID: 9492820
[TBL] [Abstract][Full Text] [Related]
26. Adjuvant chemotherapy for resectable squamous cell carcinomas of the head and neck: report on Intergroup Study 0034.
Laramore GE; Scott CB; al-Sarraf M; Haselow RE; Ervin TJ; Wheeler R; Jacobs JR; Schuller DE; Gahbauer RA; Schwade JG
Int J Radiat Oncol Biol Phys; 1992; 23(4):705-13. PubMed ID: 1618662
[TBL] [Abstract][Full Text] [Related]
27. Surgical resection is necessary to maximize tumor control in function-preserving, aggressive chemoradiation protocols for advanced squamous cancer of the head and neck (stage III and IV).
Wanebo H; Chougule P; Ready N; Safran H; Ackerley W; Koness RJ; McRae R; Nigri P; Leone L; Radie-Keane K; Reiss P; Kennedy T
Ann Surg Oncol; 2001 Sep; 8(8):644-50. PubMed ID: 11569779
[TBL] [Abstract][Full Text] [Related]
28. The importance of margins in head and neck cancer.
Baddour HM; Magliocca KR; Chen AY
J Surg Oncol; 2016 Mar; 113(3):248-55. PubMed ID: 26960076
[TBL] [Abstract][Full Text] [Related]
29. Necessity for adjuvant neck dissection in setting of concurrent chemoradiation for advanced head-and-neck cancer.
Brizel DM; Prosnitz RG; Hunter S; Fisher SR; Clough RL; Downey MA; Scher RL
Int J Radiat Oncol Biol Phys; 2004 Apr; 58(5):1418-23. PubMed ID: 15050318
[TBL] [Abstract][Full Text] [Related]
30. Is a surgical resection leaving positive margins of benefit to the patient with locally advanced squamous cell carcinoma of the head and neck: a comparative study using the intergroup study 0034 and the Radiation Therapy Oncology Group head and neck database.
Laramore GE; Scott CB; Schuller DE; Haselow RE; Ervin TJ; Wheeler R; al-Sarraf M; Gahbauer RA; Jacobs JR; Schwade JG
Int J Radiat Oncol Biol Phys; 1993 Dec; 27(5):1011-6. PubMed ID: 8262821
[TBL] [Abstract][Full Text] [Related]
31. Preoperative cisplatin and accelerated hyperfractionated radiation induces high tumor response and control rates in patients with advanced head and neck cancer.
Wanebo HJ; Glicksman AS; Landman C; Slotman G; Doolittle C; Clark J; Koness RJ
Am J Surg; 1995 Nov; 170(5):512-6. PubMed ID: 7485745
[TBL] [Abstract][Full Text] [Related]
32. Low-dose preoperative chemoradiation therapy compared with surgery alone with or without postoperative radiotherapy in patients with head and neck carcinoma.
Mücke T; Konen M; Wagenpfeil S; Kesting MR; Wolff KD; Hölzle F
Ann Surg Oncol; 2011 Oct; 18(10):2739-47. PubMed ID: 21424882
[TBL] [Abstract][Full Text] [Related]
33. Chemoradiation after surgery for high-risk head and neck cancer patients: how strong is the evidence?
Bernier J; Cooper JS
Oncologist; 2005 Mar; 10(3):215-24. PubMed ID: 15793225
[TBL] [Abstract][Full Text] [Related]
34. Adjuvant radiotherapy after transoral laser microsurgery for advanced squamous carcinoma of the head and neck.
Pradier O; Christiansen H; Schmidberger H; Martin A; Jäckel MC; Steiner W; Ambrosch P; Kahler E; Hess CF
Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1368-77. PubMed ID: 16169679
[TBL] [Abstract][Full Text] [Related]
35. Fine needle aspiration (FNA) in diagnosing recurrent squamous cell carcinoma of the head and neck: truth or consequences?
Abram AC; Nabizadeh S; Feldman PS; Cantrell RW; Levine PA
Laryngoscope; 1993 Sep; 103(9):1073-5. PubMed ID: 7689680
[No Abstract] [Full Text] [Related]
36. Induction chemotherapy for head and neck cancer: will history repeat itself?
Argiris A
J Natl Compr Canc Netw; 2005 May; 3(3):393-403. PubMed ID: 16002005
[TBL] [Abstract][Full Text] [Related]
37. Overview of combined modality therapies for head and neck cancer.
Dimery IW; Hong WK
J Natl Cancer Inst; 1993 Jan; 85(2):95-111. PubMed ID: 8418313
[TBL] [Abstract][Full Text] [Related]
38. A phase III randomized trial comparing concurrent chemotherapy and radiotherapy with radiotherapy alone in resectable stage III and IV squamous cell head and neck cancer: preliminary results.
Adelstein DJ; Saxton JP; Lavertu P; Tuason L; Wood BG; Wanamaker JR; Eliachar I; Strome M; Van Kirk MA
Head Neck; 1997 Oct; 19(7):567-75. PubMed ID: 9323144
[TBL] [Abstract][Full Text] [Related]
39. Adjuvant chemotherapy for advanced head and neck squamous carcinoma. Final report of the Head and Neck Contracts Program.
Cancer; 1987 Aug; 60(3):301-11. PubMed ID: 2885080
[TBL] [Abstract][Full Text] [Related]
40. [Reirradiation of head and neck cancers].
Comet B; Lartigau E
Cancer Radiother; 2010 Oct; 14(6-7):416-20. PubMed ID: 20810299
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
